Development & Clinical Supply

 

Aesica offers API and finished dose development as part of our full service, end-to-end pharmaceutical development and manufacturing solution.

In API development, we offer complementary services in research and development and clinical supply, supported by experience in regulation and documentation.

In finished dose, we have capabilities and expertise in formulation developmentclinical batch manufacturing, and clinical trial supply.

Through our dedicated project teams, we focus on building strong customer relationships founded on good communications and approachability, while our knowledge, experience and world-class facilities ensure all projects are delivered fully, on time, and to budget.

All our  pharma development services services are supported by our proven track record for quality and regulation, including MHRA and FDA approval, and our rigorous health and safety processes.

Click here to find out more information about our Finished Dose or API development capabilities. 

For customers with a delivery device need that cannot be met by our existing Bespak technology, we can offer a bespoke pharma device development design service to deliver your specific needs and requirements.

At Bespak, we provide the capability and expertise to reduce time to market, allowing products to be developed, tested and manufactured faster and more robustly. We use an integrated design and development approach, meaning your initial idea will be taken through the different stages of concept development and device prototyping to verification, in an efficient and effective way.

Click here to find out more about our Device Design and Development capabilities.